Literature DB >> 18824196

PET measurement of changes in D2/D3 dopamine receptor binding in a nonhuman primate during chronic deep brain stimulation of the bed nucleus of the stria terminalis.

Nicholas T Vandehey1, P Charles Garell, Joseph A Hampel, Dhanabalan Murali, Elizabeth M Smith, Richard Davidson, Alexander K Converse, R Jerry Nickles, Bradley T Christian.   

Abstract

UNLABELLED: PET imaging is a powerful tool for measuring physiological changes in the brain during deep brain stimulation (DBS). In this work, we acquired five PET scans using a highly selective D2/D3 dopamine antagonist, 18F-fallypride, to track changes in dopamine receptor availability, as measured by the distribution volume ratio (DVR), through the course of DBS in the bed nucleus of the stria terminalis (BNST) in a nonhuman primate.
METHODS: PET scans were performed on a rhesus monkey with unilateral BNST stimulation during periods of baseline, chronic high frequency (130 Hz) and low frequency (50 Hz) DBS stimulation, and during a washout period between stimulation periods. A final scan was performed with the electrode stimulation starting 110 min into the scan. Whole brain parametric images of (18)F-fallypride DVR were calculated for each condition to track changes in both striatal and extrastriatal D2/D3 availability.
RESULTS: The monkey displayed significant increases in receptor binding throughout the brain during DBS relative to baseline for 130 and 50 Hz, with changes in DVR of: caudate 42%, 51%; putamen 56%, 57%; thalamus 33%, 49%; substantia nigra 29%, 26%; and prefrontal cortex 28%, 56%, respectively. Washout and post-stimulation scans revealed DVR values close to baseline values. Activating the stimulator midway through the final scan resulted in no statistically significant changes in binding.
CONCLUSIONS: PET neuroligand imaging has demonstrated the sensitivity to track changes in dopamine D2/D3 binding during the course of DBS. These methods show great potential for providing insight into the neurochemical consequences of DBS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18824196      PMCID: PMC2638170          DOI: 10.1016/j.jneumeth.2008.08.033

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  40 in total

1.  Bed nucleus of the stria terminalis and extended amygdala inputs to dopamine subpopulations in primates.

Authors:  J L Fudge; S N Haber
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

2.  Deep brain stimulation for treatment-resistant depression.

Authors:  Helen S Mayberg; Andres M Lozano; Valerie Voon; Heather E McNeely; David Seminowicz; Clement Hamani; Jason M Schwalb; Sidney H Kennedy
Journal:  Neuron       Date:  2005-03-03       Impact factor: 17.173

Review 3.  Amygdaloid lesion-induced obesity: relation to sexual behavior, olfaction, and the ventromedial hypothalamus.

Authors:  Bruce M King
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-06-15       Impact factor: 3.619

4.  Dopaminergic agonists normalize elevated hypothalamic neuropeptide Y and corticotropin-releasing hormone, body weight gain, and hyperglycemia in ob/ob mice.

Authors:  K G Bina; A H Cincotta
Journal:  Neuroendocrinology       Date:  2000-01       Impact factor: 4.914

5.  Frequency-correlated decreases of motor cortex activity associated with subthalamic nucleus stimulation in Parkinson's disease.

Authors:  Bernhard Haslinger; Karin Kalteis; Henning Boecker; Francois Alesch; Andrés O Ceballos-Baumann
Journal:  Neuroimage       Date:  2005-08-02       Impact factor: 6.556

Review 6.  Deep brain stimulation.

Authors:  Joel S Perlmutter; Jonathan W Mink
Journal:  Annu Rev Neurosci       Date:  2006       Impact factor: 12.449

7.  Brain dopamine and obesity.

Authors:  G J Wang; N D Volkow; J Logan; N R Pappas; C T Wong; W Zhu; N Netusil; J S Fowler
Journal:  Lancet       Date:  2001-02-03       Impact factor: 79.321

Review 8.  Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review.

Authors:  M Laruelle
Journal:  J Cereb Blood Flow Metab       Date:  2000-03       Impact factor: 6.200

9.  Quantitation of striatal and extrastriatal D-2 dopamine receptors using PET imaging of [(18)F]fallypride in nonhuman primates.

Authors:  B T Christian; T K Narayanan; B Shi; J Mukherjee
Journal:  Synapse       Date:  2000-10       Impact factor: 2.562

10.  Role of the stria terminalis in food intake and body weight in rats.

Authors:  Bethany L Rollins; Samuel G Stines; Bruce M King
Journal:  Physiol Behav       Date:  2006-07-12
View more
  3 in total

1.  Effects of flow changes on radiotracer binding: Simultaneous measurement of neuroreceptor binding and cerebral blood flow modulation.

Authors:  Christin Y Sander; Joseph B Mandeville; Hsiao-Ying Wey; Ciprian Catana; Jacob M Hooker; Bruce R Rosen
Journal:  J Cereb Blood Flow Metab       Date:  2017-08-17       Impact factor: 6.200

Review 2.  Dopaminergic neurotransmission in the human brain: new lessons from perturbation and imaging.

Authors:  Ji Hyun Ko; Antonio P Strafella
Journal:  Neuroscientist       Date:  2011-05-02       Impact factor: 7.519

3.  Targeting Corticotropin-Releasing Factor Projections from the Oval Nucleus of the Bed Nucleus of the Stria Terminalis Using Cell-Type Specific Neuronal Tracing Studies in Mouse and Rat Brain.

Authors:  J Dabrowska; D Martinon; M Moaddab; D G Rainnie
Journal:  J Neuroendocrinol       Date:  2016-12       Impact factor: 3.627

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.